Juul Was Never Intended To Be a Smoking Cessation Device According To Company Insiders

Juul deliberately increased their vape pen's nicotine dosage to make the vaping experience more pleasurable and entice smokers to switch

Thursday, February 27, 2020 - The BBC estimates that over 50 million people, mostly teenagers and young adults with no history of ever smoking combustible tobacco products, are now nicotine-addicted and most will eventually transition to smoking traditional cigarettes. Most of the new e-cigarette users were lured into "vaping" by sophisticated, yet illegal market schemes employed by Juul Inc., the leading manufacturer of e-cigarettes called vape pen, targeted directly at adolescents on The Cartoon Network, and Nickelodeon who's online users were seeking homework help. The Juul vape pen is small and can be easily concealed up one's sleeve and "ripped on" while in class while the teacher's back is turned and if detected, resembles a computer portable disk drive and requires insertion into one's computer to be charged. Juul vape pen lawsuits represented by top national attorneys with vast experience and a winning track record and litigating against multinational corporations on behalf of Americans harmed by negligence and corporate greed.

Juul was able to hook an entirely new generation on nicotine by increasing the dosage of nicotine a vape drag delivered to higher levels than the human body would tolerate, initially causing the user to gasp and choke on the high dosage. It wasn't until Juul scientists figured out a chemical additive that people were able to tolerate the high nicotine dosage and the user became instantly nicotine-addicted. So says a definitive article on the subject of the behind the scenes activities at Juul that catapulted sales of vape pens from nothing to over $2 billion per year in just a couple of short years and the increases look to continue in years to come. Tobacco marketing company Altria's stake in the company was recently valued at $12 billion according to Bloomberg.

"What made the Juul a game-changer in the e-cigarette industry was not just the cool design, which immediately drew comparisons to the iPhone. It was the power and smoothness of its nicotine hit." The New York Times

The NYT's piece titled "How Juul Hooked a Generation on Nicotine" explains how Juul got away with increasing the levels of nicotine before the US Food and Drug Administration or Federal Trade Commission became aware there was a potential problem. According to the article, Juul was created in the first place to provide a product that could successfully supply a dosage of nicotine higher than its competition at the time. Executives at Juul are quoted as saying the company was more concerned about delivering higher nicotine levels and increasing sales and had no intention of helping people kick the nicotine habit. The NYT reports that "... just before the (Juul's) debut, in an interview published by The Verge in April 2015, Ari Atkins, an engineer who had worked on the team developing the Juul, said: "We don't think a lot about addiction here because we're not trying to design a cessation product at all." He added, according to the article, "Anything about health is not on our mind." The article noted that his colleagues in the interview winced."

More Recent JUUL Vape Pen Lawsuit News:

Lawyers for JUUL Vape Pen Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.